Differential effects of antidepressant subgroups on risk of acute myocardial infarction: A nested case-control study.
Rasha Alqdwah-FattouhSara Rodríguez-MartínFrancisco José de AbajoDiana González-BermejoMiguel GilAlberto García-LledóFrancisco BolúmarPublished in: British journal of clinical pharmacology (2020)
This study suggests that current use of antidepressants interfering selectively with the reuptake of serotonin, and those antagonizing the 5-HT2A receptor, are associated with a decrease in AMI risk and should be the antidepressants of choice in patients at cardiovascular risk.